日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancer

POLH 和 RAD51 基因的种系变异是与激素受体阴性早发性乳腺癌风险相关的候选变异。

Yazaki, Shu; Kitadai, Rui; Momozawa, Yukihide; Yoshida, Teruhiko; Yamanaka, Takashi; Shiino, Sho; Yamauchi, Chisako; Harano, Kenichi; Saito, Motonobu; Hirotsu, Yosuke; Aiba, Hisaki; Hamamoto, Ryuji; Shimizu, Chikako; Shimomura, Akihiko; Shimoi, Tatsunori; Sudo, Kazuki; Yoshida, Masayuki; Sunami, Kuniko; Shiraishi, Yuichi; Kuchiba, Aya; Hori, Megumi; Katanoda, Kota; Takata, Sadaaki; Ogawa, Ayumi; Torasawa, Masahiro; Mochizuki, Akifumi; Shimada, Yoko; Hiranuma, Kengo; Fujii, Erisa; Hirata, Makoto; Yamashita, Yuji; Kogawa, Takahiro; Murata, Takeshi; Fujiwara, Saori; Miyagi, Yohei; Nakagomi, Hiroshi; Tachibana, Kazunoshin; Matsuda, Koichi; Murakami, Yoshinori; Tokunaga, Katsushi; Kawai, Yosuke; Project, Biobank Japan; Omata, Masao; Ohtake, Tohru; Suto, Akihiko; Onishi, Tatsuya; Naito, Yoichi; Yamashita, Toshinari; Yonemori, Kan; Kohno, Takashi; Shiraishi, Kouya

EGFR, TP53, and CUL3 Triple Mutation in Non-Small Cell Lung Cancer and its Potentially Poor Prognosis: A Case Report and Database Analysis

非小细胞肺癌中EGFR、TP53和CUL3三重突变及其潜在不良预后:病例报告和数据库分析

Hatano, Hiroto; Yoshida, Tatsuya; Higashiyama, Ryoko; Torasawa, Masahiro; Uehara, Yuji; Ohe, Yuichiro

Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome-wide association and whole genome sequencing analyses

通过全基因组关联分析和全基因组测序分析鉴定与肺腺癌风险相关的端粒维持基因变异

Shiraishi, Kouya; Takahashi, Atsushi; Momozawa, Yukihide; Daigo, Yataro; Kaneko, Syuzo; Kawaguchi, Takahisa; Kunitoh, Hideo; Matsumoto, Shingo; Horinouchi, Hidehito; Goto, Akiteru; Honda, Takayuki; Shimizu, Kimihiro; Torasawa, Masahiro; Takayanagi, Daisuke; Saito, Motonobu; Saito, Akira; Ohe, Yuichiro; Watanabe, Shun-Ichi; Goto, Koichi; Tsuboi, Masahiro; Tsuchihara, Katsuya; Takata, Sadaaki; Aoi, Tomomi; Takano, Atsushi; Kobayashi, Masashi; Miyagi, Yohei; Tanaka, Kazumi; Suzuki, Hiroyuki; Maeda, Daichi; Yamaura, Takumi; Matsuda, Maiko; Shimada, Yoko; Mizuno, Takaaki; Sakamoto, Hiromi; Yoshida, Teruhiko; Goto, Yasushi; Yoshida, Tatsuya; Yamaji, Taiki; Sonobe, Makoto; Toyooka, Shinichi; Yoneda, Kazue; Masago, Katsuhiro; Tanaka, Fumihiro; Hara, Megumi; Fuse, Nobuo; Nishizuka, Satoshi S; Motoi, Noriko; Sawada, Norie; Nishida, Yuichiro; Kumada, Kazuki; Takeuchi, Kenji; Tanno, Kozo; Yatabe, Yasushi; Sunami, Kuniko; Hishida, Tomoyuki; Miyazaki, Yasunari; Ito, Hidemi; Amemiya, Mitsuhiro; Totsuka, Hirohiko; Nakayama, Haruhiko; Yokose, Tomoyuki; Ishigaki, Kazuyoshi; Nagashima, Toshiteru; Ohtaki, Yoichi; Imai, Kazuhiro; Takasawa, Ken; Minamiya, Yoshihiro; Kobayashi, Kazuma; Okubo, Kenichi; Wakai, Kenji; Shimizu, Atsushi; Yamamoto, Masayuki; Iwasaki, Motoki; Matsuda, Koichi; Inazawa, Johji; Shiraishi, Yuichi; Nishikawa, Hiroyoshi; Murakami, Yoshinori; Kubo, Michiaki; Matsuda, Fumihiko; Kamatani, Yoichiro; Hamamoto, Ryuji; Matsuo, Keitaro; Kohno, Takashi

Rapid Response to Lenvatinib and Disease Flare After Discontinuation in a Patient With Thymic Carcinoma Harboring KIT Exon 11 Mutation: A Case Report

一例携带KIT基因11号外显子突变的胸腺癌患者,在接受乐伐替尼治疗后病情迅速缓解,但停药后出现疾病复发:病例报告

Torasawa, Masahiro; Yoshida, Tatsuya; Shiraishi, Kouya; Goto, Naoko; Ueno, Toshihide; Ichikawa, Hitoshi; Yagishita, Shigehiro; Kohsaka, Shinji; Goto, Yasushi; Yatabe, Yasushi; Hamada, Akinobu; Mano, Hiroyuki; Ohe, Yuichiro

Real-world outcomes of treatment strategy between first-line osimertinib, first/second-generation EGFR-TKIs followed by osimertinib and without osimertinib in advanced EGFR-mutant NSCLC

在晚期 EGFR 突变型非小细胞肺癌中,一线治疗奥希替尼、第一/二代 EGFR-TKI 序贯奥希替尼以及不使用奥希替尼的治疗策略的真实世界疗效比较

Uehara, Y; Takeyasu, Y; Yoshida, T; Tateishi, A; Torasawa, M; Hosomi, Y; Masuda, K; Shinno, Y; Matsumoto, Y; Okuma, Y; Goto, Y; Horinouchi, H; Yamamoto, N; Ohe, Y

Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterations

晚期非小细胞肺癌患者在接受免疫检查点抑制剂治疗后,因酪氨酸激酶抑制剂治疗而导致严重不良事件的发生率(伴有致癌驱动基因改变)

Shimoda, Yukiko; Yoshida, Tatsuya; Miyakoshi, Jun; Torasawa, Masahiro; Tateishi, Akiko; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Ohe, Yuichiro

Disease progression status during initial immune checkpoint inhibitor (ICI) affects the clinical outcome of ICI retreatment in advanced non-small cell lung cancer patients

在晚期非小细胞肺癌患者中,初始免疫检查点抑制剂(ICI)治疗期间的疾病进展状态会影响ICI再治疗的临床结果。

Torasawa, Masahiro; Yoshida, Tatsuya; Takeyasu, Yuki; Shimoda, Yukiko; Tateishi, Akiko; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Takahashi, Kazuhisa; Ohe, Yuichiro

Co-occurring KEAP1 and TP53 mutations in lung squamous cell carcinoma induced primary resistance to thoracic radiotherapy: A case report

肺鳞状细胞癌中KEAP1和TP53基因共突变导致胸部放射治疗原发性耐药:病例报告

Nishimura, Rumi; Yoshida, Tatsuya; Torasawa, Masahiro; Kashihara, Tairo; Ohe, Yuichiro

Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non-small cell lung cancer from proteomic profiling of circulating extracellular vesicles

通过循环细胞外囊泡的蛋白质组学分析,探索性分析预测局部晚期非小细胞肺癌患者在度伐利尤单抗巩固治疗期间发生肺炎的风险

Torasawa, Masahiro; Horinouchi, Hidehito; Yagishita, Shigehiro; Utsumi, Hirofumi; Okuda, Keitaro; Takekoshi, Daisuke; Ito, Saburo; Wakui, Hiroshi; Murata, Saori; Kaku, Sawako; Okuma, Kae; Matsumoto, Yuji; Shinno, Yuki; Okuma, Yusuke; Yoshida, Tatsuya; Goto, Yasushi; Yamamoto, Noboru; Araya, Jun; Ohe, Yuichiro; Fujita, Yu

CT Guided Needle Biopsy of Peripheral Lesions-Lesion Characteristics That May Increase the Diagnostic Yield and Reduce the Complication Rate

CT引导下外周病变针吸活检——可能提高诊断率并降低并发症发生率的病变特征

Tajima, Manabu; Togo, Shinsaku; Ko, Ryo; Koinuma, Yoshika; Sumiyoshi, Issei; Torasawa, Masahiro; Kikuchi, Nao; Shiraishi, Akihiko; Sasaki, Shinichi; Kyogoku, Shinsuke; Kuwatsuru, Ryohei; Takahashi, Kazuhisa